Claudio Laudani/X
Nov 18, 2025, 15:08
Claudio Laudani: DOACs Have Transformed the Landscape of Anticoagulation
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Direct oral anticoagulants (DOACs) have transformed the landscape of anticoagulation, offering more predictable pharmacology, improved safety, and easier management compared to vitamin K antagonists.
In this comprehensive review, we examine:
- Pharmacokinetic and pharmacodynamic profiles of apixaban, rivaroxaban, dabigatran, and edoxaban.
- Evidence supporting their use across atrial fibrillation, venous thromboembolism, cancer-associated thrombosis, and atherosclerosis compared with other antithrombotic strategies.
- How to optimize DOAC therapy in vulnerable scenarios (renal impairment, elderly patients, perioperative management).
- Remaining gaps and unmet clinical needs where further research is required, such as patients with rheumatic heart disease, mechanical heart valves, antiphospholipid syndrome, and patients with LVAD.”
Read the full article here.
Article: Safety and optimal use of direct oral anticoagulant therapy
Authors: Claudio Laudani, Luis Ortega-Paz, Ali Zgheib, Georges El Khoury, Mohmmad Alawajneh, Maryam Farahmandsadr, Davide Capodanno, Dominick J Angiolillo
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia
-
May 23, 2026, 05:29Understanding Hepatitis A, B, and C During Hepatitis Awareness Month – UNC Health
-
May 23, 2026, 03:55WFH Initiative Brings Hope to the Hemophilia Community in India
-
May 23, 2026, 03:47Satyam Arora: Welcoming the New ISBT Board for the 2026 Term
-
May 23, 2026, 03:33Brig Tathagata Chatterjee: Connecting With World Leaders in Hematology at ISH Congress
-
May 23, 2026, 03:18Mathangi Kumar: Dental Management Strategies for Congenital Hemophilia
-
May 23, 2026, 03:02Maitri Vaishnav: Anatomical Variability and Surgical Relevance of Corona Mortis
-
May 23, 2026, 02:26Muhammad Hashim: When the Blood Smear Told a Different Story Behind a ‘Critical’ Platelet Count